Symbol | Description | logFC | FC | Layer |
---|---|---|---|---|
Up | ||||
COL6A6 | collagen, type VI, alpha 6 | 2,08 | 4,22 | D |
CD1B | CD1b molecule | 1,84 | 3,57 | D |
SPRR1B | small proline-rich protein 1B | 1,68 | 3,20 | E |
CCL22 | chemokine (C-C motif) ligand 22 | 1,65 | 3,13 | D |
MMP9 | matrix metallopeptidase 9 (gelatinase B, 92 kDa gelatinase, 92 kDa type IV collagenase) | 1,51 | 2,84 | D |
IL13RA2 | interleukin 13 receptor, alpha 2 | 1,46 | 2,74 | D |
CCL26 | chemokine (C-C motif) ligand 26 | 1,37 | 2,59 | D |
SASH3 | SAM and SH3 domain containing 3 | 1,35 | 2,56 | D |
IL36RN | interleukin 36 receptor antagonist | 1,35 | 2,55 | E |
CCL13 | chemokine (C-C motif) ligand 13 | 1,27 | 2,41 | D |
KIAA1644 | KIAA1644 | 1,26 | 2,39 | D |
IL12RB1 | interleukin 12 receptor, beta 1 | 1,23 | 2,34 | D |
XCL2 | chemokine (C motif) ligand 2 | 1,21 | 2,31 | D |
CCL5 | chemokine (C-C motif) ligand 5 | 1,21 | 2,31 | D |
ADAMDEC1 | ADAM-like, decysin 1 | 1,19 | 2,29 | D |
TIFAB | TRAF-interacting protein with forkhead-associated domain, family member B | 1,18 | 2,27 | D |
P2RY1 | purinergic receptor P2Y, G-protein coupled, 1 | 1,16 | 2,23 | E |
PIK3CG | phosphatidylinositol-4,5-bisphosphate 3-kinase, catalytic subunit gamma | 1,15 | 2,22 | D |
FAM124B | family with sequence similarity 124B | 1,14 | 2,21 | D |
SLAMF8 | SLAM family member 8 | 1,12 | 2,18 | D |
CXADR | coxsackie virus and adenovirus receptor | 1,12 | 2,17 | E |
GPSM3 | G-protein signaling modulator 3 | 1,11 | 2,16 | D |
HCK | hemopoietic cell kinase | 1,09 | 2,13 | D |
LOC100288860 | uncharacterized LOC100288860 | 1,09 | 2,12 | E |
MMP3 | matrix metallopeptidase 3 (stromelysin 1, progelatinase) | 1,08 | 2,11 | D |
CD1E | CD1e molecule | 1,07 | 2,10 | D |
KLRK1 | killer cell lectin-like receptor subfamily K, member 1 | 1,06 | 2,09 | D |
GBP1 | guanylate binding protein 1, interferon-inducible | 1,06 | 2,09 | |
IL23A | interleukin 23, alpha subunit p19 | 1,05 | 2,08 | D |
LYN | v-yes-1 Yamaguchi sarcoma viral related oncogene homolog | 1,05 | 2,07 | D |
C5orf20 | chromosome 5 open reading frame 20 | 1,05 | 2,06 | D |
CCL8 | chemokine (C-C motif) ligand 8 | 1,04 | 2,06 | D |
RELB | v-rel avian reticuloendotheliosis viral oncogene homolog B | 1,04 | 2,06 | |
ACPP | acid phosphatase, prostate | 1,03 | 2,05 | E |
TRAT1 | T cell receptor associated transmembrane adaptor 1 | 1,03 | 2,04 | D |
PTX3 | pentraxin 3, long | 1,03 | 2,04 | D |
CD48 | CD48 molecule | 1,03 | 2,04 | D |
FPR3 | formyl peptide receptor 3 | 1,02 | 2,03 | D |
TGM3 | transglutaminase 3 | 1,02 | 2,03 | E |
CXCL11 | chemokine (C-X-C motif) ligand 11 | 1,02 | 2,03 | |
MAP4K1 | mitogen-activated protein kinase kinase kinase kinase 1 | 1,02 | 2,02 | D |
CD6 | CD6 molecule | 1,02 | 2,02 | D |
SELPLG | selectin P ligand | 1,01 | 2,02 | D |
ZC3H12D | zinc finger CCCH-type containing 12D | 1,01 | 2,01 | D |
C15orf48 | chromosome 15 open reading frame 48 | 1,00 | 2,00 | E |
Down | ||||
PM20D1 | peptidase M20 domain containing 1 | −2,63 | −6,19 | |
KRT79 | keratin 79 | −2,04 | −4,13 | |
GAL | galanin/GMAP prepropeptide | −2,02 | −4,06 | |
ELOVL3 | ELOVL fatty acid elongase 3 | −1,71 | −3,26 | |
CYP4F8 | cytochrome P450, family 4, subfamily F, polypeptide 8 | −1,64 | −3,11 | |
HAO2 | hydroxyacid oxidase 2 (long chain) | −1,63 | −3,10 | |
FADS2 | fatty acid desaturase 2 | −1,49 | −2,80 | |
ANGPTL7 | angiopoietin-like 7 | −1,40 | −2,63 | D |
CUX2 | cut-like homeobox 2 | −1,36 | −2,56 | |
PON3 | paraoxonase 3 | −1,35 | −2,55 | E |
SGK2 | serum/glucocorticoid regulated kinase 2 | −1,32 | −2,50 | |
MSMB | microseminoprotein, beta- | −1,31 | −2,47 | E |
FADS1 | fatty acid desaturase 1 | −1,30 | −2,46 | D |
BPY2 | basic charge, Y-linked, 2 | −1,29 | −2,45 | |
FAR2 | fatty acyl CoA reductase 2 | −1,29 | −2,44 | D |
MUC7 | mucin 7, secreted | −1,23 | −2,35 | |
FA2H | fatty acid 2-hydroxylase | −1,20 | −2,30 | |
ABHD12B | abhydrolase domain containing 12B | −1,18 | −2,27 | E |
PNPLA3 | patatin-like phospholipase domain containing 3 | −1,18 | −2,27 | E |
ACOX2 | acyl-CoA oxidase 2, branched chain | −1,11 | −2,16 | D |
PSORS1C2 | psoriasis susceptibility 1 candidate 2 | −1,10 | −2,15 | E |
KRT19 | keratin 19 | −1,08 | −2,11 | |
ATP6V1B1 | ATPase, H+ transporting, lysosomal 56/58 kDa, V1 subunit B1 | −1,07 | −2,10 | |
SCGB2B2 | secretoglobin, family 2B, member 2 | −1,07 | −2,09 | |
MOGAT1 | monoacylglycerol O-acyltransferase 1 | −1,07 | −2,09 | |
NSUN7 | NOP2/Sun domain family, member 7 | −1,07 | −2,09 | E |
COCH | cochlin | −1,05 | −2,07 | E |
IL20RA | interleukin 20 receptor, alpha | −1,05 | −2,07 | E |
SEMA3B | sema domain, immunoglobulin domain (Ig), short basic domain, secreted, (semaphorin) 3B | −1,03 | −2,05 | D |
RHPN2 | rhophilin, Rho GTPase binding protein 2 | −1,03 | −2,05 | |
AWAT1 | acyl-CoA wax alcohol acyltransferase 1 | −1,03 | −2,04 | |
TMC4 | transmembrane channel-like 4 | −1,03 | −2,04 | |
GPRC5A | G protein-coupled receptor, class C, group 5, member A | −1,02 | −2,03 | |
TRHDE-AS1 | TRHDE antisense RNA 1 | −1,02 | −2,03 | |
AQP5 | aquaporin 5 | −1,02 | −2,03 | |
LINC00663 | long intergenic non-protein coding RNA 663 | −1,02 | −2,02 | |
ZNF471 | zinc finger protein 471 | −1,01 | −2,02 | |
CYP2J2 | cytochrome P450, family 2, subfamily J, polypeptide 2 | −1,01 | −2,02 | E |
MEGF10 | multiple EGF-like-domains 10 | −1,01 | −2,01 | |
FAXDC2 | fatty acid hydroxylase domain containing 2 | −1,00 | −2,01 | D |
SLC13A2 | solute carrier family 13 (sodium-dependent dicarboxylate transporter), member 2 | −1,00 | −2,01 |